8:01 AM ET
10-Q
Financial Results
Vivani Medical Q3 2026 Results: Net Loss of $7.25M, Loss Widens
Vivani Medical, Inc. is a clinical-stage company with a cash balance of $14.6 million as of September 30, 2026, down from $16.2 million at year-end 2025. The company remains pre-revenue, focusing on the development of product candidates like NPM-139 and NPM-133, and reported a total liability of $22.1 million primarily driven by lease obligations.
- Key figure
- Net loss $7.25M